Akiyo Morinibu
Kyoto University(JP)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Epigenetics and DNA Methylation, Nanoplatforms for cancer theranostics, High Altitude and Hypoxia, Cancer Research and Treatments
Most-Cited Works
- → Correction: Corrigendum: Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate toward tumour blood vessels(2013)676 cited
- → UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α(2015)232 cited
- → Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels(2012)171 cited
- → The Akt/mTOR Pathway Assures the Synthesis of HIF-1α Protein in a Glucose- and Reoxygenation-dependent Manner in Irradiated Tumors(2008)159 cited
- → HIF-1-mediated metabolic reprogramming reduces ROS levels and facilitates the metastatic colonization of cancers in lungs(2014)116 cited
- → UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization(2017)98 cited
- → Aberrant IDH3α expression promotes malignant tumor growth by inducing HIF-1-mediated metabolic reprogramming and angiogenesis(2014)97 cited
- → A circadian clock gene, PER2, activates HIF‐1 as an effector molecule for recruitment of HIF‐1α to promoter regions of its downstream genes(2017)80 cited
- → Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy(2009)76 cited
- → The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts(2007)61 cited